Molecular Pathological Epidemiology (MPE) is an interdisciplinary field that integrates molecular pathology with epidemiology to understand disease heterogeneity. It examines how environmental, lifestyle, and genetic factors influence specific molecular subtypes of disease, particularly in cancer. In public health, MPE provides insights into why individuals respond differently to the same exposures or treatments. This approach improves risk stratification, prevention strategies, and treatment effectiveness by linking population-level data with molecular disease characteristics. MPE supports precision prevention and policy development by identifying high-risk groups and tailored interventions. By bridging laboratory science and population health, molecular pathological epidemiology advances more targeted, effective, and equitable public health strategies.
Title : Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries
Sebastiano Venturi, Department of Public Health of Rimini, Italy
Title : Specific strategies over the life course for early identification, prevention, treatment, and long-term support
Christopher Ashton, Center for Recovery, Canada
Title : Population health, public health and the social determinants of health: The state of the science
Adele Ann Webb, Strategic Education, Inc., United States
Title : The nutritional management of healthy menu plans
Iuliana Vintila, Dunărea de Jos University of Galați, Romania
Title : Healthcare system profiles and pandemic outcomes: A cross-country multi-dimensional scaling analysis of Cuba, Spain, Italy, and Germany
Giuseppe Orlando, University of Bari Aldo Moro, Italy
Title : Change your genes – change your life: Epigenetics of longevity
Kenneth R Pelletier, USCF School of Medicine, United States